These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15181607)

  • 1. Mucosal damage: a major risk factor for severe complications after cytotoxic therapy.
    Peterson DE; Cariello A
    Semin Oncol; 2004 Jun; 31(3 Suppl 8):35-44. PubMed ID: 15181607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
    Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
    N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant.
    Beaven AW; Shea TC
    Drugs Today (Barc); 2007 Jul; 43(7):461-73. PubMed ID: 17728847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment.
    Saadeh CE
    Pharmacotherapy; 2005 Apr; 25(4):540-54. PubMed ID: 15977916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis.
    Demarosi F; Bez C; Carrassi A
    Minerva Stomatol; 2002 May; 51(5):173-86. PubMed ID: 12070468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis.
    McDonnell AM; Lenz KL
    Ann Pharmacother; 2007 Jan; 41(1):86-94. PubMed ID: 17190850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation therapy and chemotherapy-induced oral mucositis.
    Volpato LE; Silva TC; Oliveira TM; Sakai VT; Machado MA
    Braz J Otorhinolaryngol; 2007; 73(4):562-8. PubMed ID: 17923929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mucositis--a major non-hematologic complication of high-dose chemotherapy and radiotherapy--pathogenesis, prevention and treatment].
    Piatkowska-Jakubas B; Darczuk D; Chomyszyn-Gajewska M; Skotnicki AB
    Przegl Lek; 2003; 60(12):815-20. PubMed ID: 15058023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral mucositis in myelosuppressive cancer therapy.
    Epstein JB; Schubert MM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Sep; 88(3):273-6. PubMed ID: 10503852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of oral mucositis on morbidity and mortality in bone marrow transplant.
    Gabriel DA; Shea T; Olajida O; Serody JS; Comeau T
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):76-83. PubMed ID: 14727245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
    Worthington HV; Clarkson JE; Eden OB
    Cochrane Database Syst Rev; 2006 Apr; (2):CD000978. PubMed ID: 16625538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer therapy-related oral mucositis.
    Redding SW
    J Dent Educ; 2005 Aug; 69(8):919-29. PubMed ID: 16081575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.
    Scully C; Epstein J; Sonis S
    Head Neck; 2003 Dec; 25(12):1057-70. PubMed ID: 14648865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): experimental studies in mice.
    Dörr W; Bässler S; Reichel S; Spekl K
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):881-7. PubMed ID: 15936573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.
    Vadhan-Raj S; Trent J; Patel S; Zhou X; Johnson MM; Araujo D; Ludwig JA; O'Roark S; Gillenwater AM; Bueso-Ramos C; El-Naggar AK; Benjamin RS
    Ann Intern Med; 2010 Sep; 153(6):358-67. PubMed ID: 20855800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based oral care for oral mucositis.
    Farrington M; Cullen L; Dawson C
    ORL Head Neck Nurs; 2013; 31(3):6-15. PubMed ID: 24069711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current approaches in prevention and therapy of chemo- and radiotherapy-induced oral mucositis].
    Rosenthal C; Karthaus M
    Wien Med Wochenschr; 2001; 151(3-4):53-65. PubMed ID: 11789420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
    Clarkson JE; Worthington HV; Eden OB
    Cochrane Database Syst Rev; 2003; (3):CD000978. PubMed ID: 12917895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
    Stiff PJ; Emmanouilides C; Bensinger WI; Gentile T; Blazar B; Shea TC; Lu J; Isitt J; Cesano A; Spielberger R
    J Clin Oncol; 2006 Nov; 24(33):5186-93. PubMed ID: 16391299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies for management of oral mucositis in cancer patients.
    Peterson DE
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):9-13. PubMed ID: 16499139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.